Why Novavax Stock Is Skyrocketing Today

Shares of Novavax (NASDAQ: NVAX), a clinical-stage vaccine company, are poised to continue their amazing run today. The biotech's stock is already up by a noteworthy 20% in pre-market action Tuesday morning.

Novavax's shares are heating up yet again this morning in response to the official start of the combined phase 1/2 trial for the company's COVID-19 vaccine candidate, NVX‑CoV2373. Data from the phase 1 portion of the trial is expected to be released as soon as this July. 

Image source: Getty Images.

Continue reading

Source Fool.com